Literature DB >> 9884676

The use of psychostimulants in the pediatric patient.

S R Pliszka1.   

Abstract

The psychostimulant drugs have a long history of safe and effective usage in the treatment of ADHD. They remain the drugs of first choice in this condition. Children with ADHD should be aggressively treated with at least two different classes of psychostimulants before moving to nonpsychostimulant agents. As long as side effects are not troublesome, higher dosages may be used to adequately control the ADHD symptoms, and such high dosages do not impair learning. No evidence shows long-term effects of psychostimulants on growth. Effective use of the psychostimulants is essential for any clinician involved in the treatment of children with ADHD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884676     DOI: 10.1016/s0031-3955(05)70063-8

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  4 in total

1.  Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.

Authors:  Sergio D Iñiguez; Brandon L Warren; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

Review 2.  Atomoxetine.

Authors:  Dene Simpson; Caroline M Perry
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

3.  The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients.

Authors:  Andrew R. Adesman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-04

Review 4.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.